Boston Scientific Corp. reported positive data for two key atrial fibrillation therapies at AF Symposium 2025 on January 17.

Boston Scientific (NYSE: BSX) today reported data from separate studies backing its Farapulse and Watchman FLX systems.

Boston Scientific Corp (NYSE:BSX), a $144.82 billion medical device manufacturer with strong financial health according to InvestingPro analysis, has received preliminary court approval for a ...

Boston Scientific (BSX) announced data supporting the use of the FARAPULSE Pulsed Field Ablation System* and the WATCHMAN ...

CardioFocus today announced the publication of 12-month data from a study of its pulsed field ablation (PFA) system for ...

Investors in Boston Scientific Corp. (Symbol: BSX) saw new options begin trading today, for the February 2025 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...

1 Early clinical studies suggest that PFA performs similarly to thermal ablation in terms of acute-term and medium-term efficacy, with purported safety and efficiency advantages.2 The FARAPULSE system ...

Boston police have nine police officers and eight civilians who manage the detail system, using phone calls and actual printed forms that need to be filled out and turned back in. This, for a ...

China's scientific journals have made significant strides in their academic influence and quality improvements over the past decade, according to the Blue Book on China's Scientific Journal ...

Several inches of snow fell Friday evening across parts of the Northeast, with snowflakes even reaching the Interstate 95 corridor from Philadelphia through New York and into Boston for a period ...